𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of VEGF and VEGFR2 in tumors during neoadjuvant therapy of patients with breast cancer

✍ Scribed by E. A. Kim; E. S. Gershtein; I. V. Vysotskaya; N. E. Kushlinskii

Book ID
106357877
Publisher
Springer US
Year
2008
Tongue
English
Weight
327 KB
Volume
145
Category
Article
ISSN
0007-4888

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Anti-VEGF-A therapy reduces lymphatic ve
Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model
✍ Brandt Whitehurst; Michael J. Flister; Juhi Bagaitkar; Lisa Volk; Christopher M. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 991 KB

## Abstract Because metastasis contributes significantly to cancer mortality, understanding its mechanisms is crucial to developing effective therapy. Metastasis is facilitated by lymphangiogenesis, the growth of new intratumoral or peritumoral lymphatic vessels from pre‐existing vessels. Vascular